Recombinant human endostatin combined with chemotherapy for advanced squamous cell lung cancer: a meta-analysis

BACKGROUND: This paper aims to compare the efficacy and safety of recombinant human endostatin combined with chemotherapy in patients with squamous cell lung cancer (SqCLC). METHODS: We searched the Cochrane Library, PubMed, Embase, CNKI, Wanfang database, Metstr, VIP, and others and manually search...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:World J Surg Oncol
Hlavní autoři: Feng, Li, Wang, Zhicong, Jing, Li, Zhou, Zhiguo, Shi, Shuai, Deng, Ruoying, Liu, Yibing, Meng, Qingju
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2021
Témata:
Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7912552/
https://ncbi.nlm.nih.gov/pubmed/33637113
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12957-021-02161-1
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky